These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30668346)

  • 21. A comparative pharmacogenomic analysis of three classic TCM prescriptions for coronary heart disease based on molecular network modeling.
    Zhang YY; Zhao ZD; Kong PY; Gao L; Yu YN; Liu J; Wang PQ; Li B; Zhang XX; Yang LQ; Wang Z
    Acta Pharmacol Sin; 2020 Jun; 41(6):735-744. PubMed ID: 32051552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Network Pharmacology Study on Molecular Mechanisms of Zhishi Xiebai Guizhi Decoction in the Treatment of Coronary Heart Disease.
    Gao J; Pan Y; Zhao Y; Li H; Mi Z; Chen H; Tan X
    Evid Based Complement Alternat Med; 2021; 2021():3574321. PubMed ID: 34966435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
    Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
    J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
    Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
    J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation.
    Yan LL; Zhang WY; Wei XH; Yan L; Pan CS; Yu Y; Fan JY; Liu YY; Zhou H; Han JY; Yao XS
    Front Physiol; 2018; 9():296. PubMed ID: 29674972
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemical profile and potential mechanisms of Huo-Tan-Chu-Shi decoction in the treatment of coronary heart disease by UHPLC-Q/TOF-MS in combination with network pharmacology analysis and experimental verification.
    He L; Jiang H; Lan T; Qiu Y; Yang K; Chen K; Yao X; Yao Z; Lu W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122729. PubMed ID: 33992976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics.
    Jiang Y; He Q; Zhang T; Xiang W; Long Z; Wu S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach.
    Yang Y; Su C; Zhang XZ; Li J; Huang SC; Kuang HF; Zhang QY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123712. PubMed ID: 37060624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A network pharmacology approach to discover action mechanisms of Yangxinshi Tablet for improving energy metabolism in chronic ischemic heart failure.
    Wu RM; Jiang B; Li H; Dang WZ; Bao WL; Li HD; Ye G; Shen X
    J Ethnopharmacol; 2020 Jan; 246():112227. PubMed ID: 31509780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease.
    Sheng S; Yang ZX; Xu FQ; Huang Y
    Chin J Integr Med; 2021 Feb; 27(2):106-114. PubMed ID: 32388823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine.
    Yang HY; Liu ML; Luo P; Yao XS; Zhou H
    Phytomedicine; 2022 Sep; 104():154268. PubMed ID: 35777118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic profile and potential mechanisms of Wendan decoction on coronary heart disease by ultra-high-performance quadrupole time of flight-mass spectrometry combined with network pharmacology analysis.
    Wang Q; Chen J; Zhang Y; Xu D; Wu H; Lin P; He L; Qin Z; Yao Z
    J Sep Sci; 2023 Jan; 46(1):e2200456. PubMed ID: 36300722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the active compounds and drug targets of Chinese medicine in heart failure based on the PPARs-RXRα pathway.
    Shao M; Guo D; Lu W; Chen X; Ma L; Wu Y; Zhang X; Wang Q; Wang X; Li W; Wang Q; Wang W; Li C; Wang Y
    J Ethnopharmacol; 2020 Jul; 257():112859. PubMed ID: 32294506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.
    Zhang YQ; Guo QY; Li QY; Ren WQ; Tang SH; Wang SS; Liang RX; Li DF; Zhang Y; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2018 Jun; 39(6):975-987. PubMed ID: 28858293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases.
    Li G; Xu Q; Han K; Yan W; Huang C
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32990315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of the Compatibility of Gualou and Xiebai on Pharmacokinetics of Quercetin in Gualou].
    Yan HY; Zou CC; Wei ML; Huang X; Zhang YH; Chen XJ
    Zhong Yao Cai; 2015 Jul; 38(7):1472-5. PubMed ID: 26946846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study on the Active Constituents and Molecular Mechanism of Zhishi Xiebai Guizhi Decoction in the Treatment of CHD Based on UPLC-UESI-Q Exactive Focus, Gene Expression Profiling, Network Pharmacology, and Experimental Validation.
    Liu Y; He X; Di Z; Du X
    ACS Omega; 2022 Feb; 7(5):3925-3939. PubMed ID: 35155889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ["Multi-component-multi-target-multi-pathway" mechanism of Kuihua Hugan Tablets based on network pharmacology].
    Shen HB; Zhou YN; Zheng J; Zhu RH
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1464-1474. PubMed ID: 31090306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and Prospective.
    Luo TT; Lu Y; Yan SK; Xiao X; Rong XL; Guo J
    Chin J Integr Med; 2020 Jan; 26(1):72-80. PubMed ID: 30941682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease.
    Ma X; Wang Q; Liu C; Liu J; Luo G; He L; Yuan T; He RR; Yao Z
    Phytomedicine; 2023 Jun; 114():154749. PubMed ID: 36931097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.